The Winner of the Venture Challenge Fall 2020 is SLAM Orthopedic!
This year’s winners of the Venture Challenge were uniquely announced in front of an online audience at…
This year’s winners of the Venture Challenge were uniquely announced in front of an online audience at…
This year’s winners of the Venture Challenge were uniquely announced in front of an online audience at…
As of this week, enterprising researchers can submit their candidacy for the Fall edition of the Venture…
Six innovative teams were selected this spring to participate in the Venture Challenge, a coaching programme for…
During the Investors Forumfourteen young companies had the opportunity to present their company to interesting partners and discuss…
Targeting growth in the fight against cancer In front of an audience of companies and organisations whose…
Last week the Venture Challenge Fall 2019 kicked off with five Life Sciences & Health startups participating…
Accelerating innovative startups and scale-ups together As of September 2019, LifeSciences@Work (LS@W) welcomes Pivot Park as new…
Na een niertransplantatie hebben nierpatiënten verhoogde kans op virusinfecties, zoals het BK-virus. Op dit moment is er…
What is MedtechPartners? MedtechPartners is an unique national platform that brings medical innovation to life by accelerating…
The Netherlands is home to 2,900 innovative Life Sciences businesses, including 420 biopharmaceutical companies, and the European…
This international mentoring program is supported by main partner Health~Holland and designed to effectively help you scale-up…
What is MedtechPartners? MedtechPartners is an unique national platform that brings medical innovation to life by accelerating…
Dutch startup Cyclomics is developing a liquid biopsy test for tumor recurrence and therapy response monitoring that…
Ncardia, winner of the Venture Challenge 2009, announced today that following retraction of the Cor.4U product line…
The Association of Dutch Health Foundations (SGF) and the Top Sector Life Sciences & Health (LSH) have made €…
First-in-class drugs through targeted stabilisation of protein complexes During the Dutch Biotech Event where biotech companies of…
Every year LifeSciences@Work organises two Venture Challenges for start-ups that want to translate their idea into a…
Den Haag, 21 maart 2019 – Carmen van Vilsteren is per 1 april 2019 het nieuwe boegbeeld…
Dengue-virus maakt jaarlijks 400 miljoen mensen ziek Wereldwijd worden elk jaar zo’n vierhonderd miljoen mensen ziek door…
Tackling a stubborn drug problem If drugs do not dissolve well, they cannot be absorbed by the…
Health~Holland is proud to present the latest and greatest of the Life Sciences & Health sector. This…
Charles River will offer access to ToxTracker®, expanding the Company’s portfolio of genetic toxicology assays Charles River…
Today at the Dutch Life Science Conference, Chrétien Herben, director of the LifeSciences@Work Accelerator, announced SeraNovo as…
LifeSciences@Work started in 2008, and now in 2018, it proudly celebrates its tenth anniversary. To mark this…
Het midden- en kleinbedrijf (MKB) werkzaam in de Life Sciences & Health (LSH) sector is doorgaans op…
The new Health~Holland Update April 2018 edition is out now. In this spring magazine we highlight that…
De Topsector Life Sciences & Health (Health~Holland) publiceert het nieuwe Kennis- en Innovatiecontract 2018-2019, getiteld Glow~Motion. Dit…
We are pleased to send you the last Health~Holland Update of 2017, our magazine that brings you…
We are pleased to share the Health~Holland Update of September 2017, the magazine that brings you the…
The Hague, 1st of Augustus 2017 – Today Health~Holland, Top Sector Life Sciences & Health (LSH), launches…
RegMed XB is the new institute for regenerative medicine. In REGMED XB (REGenerative MEDicine crossing Borders) Dutch health…
Health~Holland publishes a bi-monthly online magazine: the Health~Holland update. The Update May 2016 informs you about the latest…
The first Health~Holland Update of 2016 informs you about the latest developments at Top Sector LSH, including…
Recent Comments